Hiroyuki Baba

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 8

Top Topics

Rheumatoid Arthritis

Top Venues

The Journal of pharmacology and experimental therapeutics

Rheumatology advances in practice

Rheumatology (Oxford, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Hiroyuki Baba, Tadashi Hosoya, Ryosuke Ishida, Kenpei Tai, Saki Hatsuzawa, Yuma Kondo, Hiroyuki Kusuhara, Hiroyuki Kagechika, Shinsuke Yasuda
Anti-inflammatory effects of a novel NF-kB inhibitory derivative derived from pyrazolo[3,4- d ]pyrimidine in three inflammation models . The Journal of pharmacology and experimental therapeutics (2024)
Takumi Matsumoto, Takahiko Sugihara, Tadashi Hosoya, Tatsuro Ishizaki, Kanae Kubo, Mari Kamiya, Hiroyuki Baba, Marina Tsuchida, Fumio Hirano, Masayo Kojima, Nobuyuki Miyasaka, Masayoshi Harigai
Effectiveness and safety of treat-to-target strategy for methotrexate-naïve rheumatoid arthritis patients >75 years of age. Rheumatology advances in practice 8 (1) (2024)
Hiroyuki Baba, Tadashi Hosoya, Ryosuke Ishida, Kenpei Tai, Saki Hatsuzawa, Yuma Kondo, Hiroyuki Kusuhara, Hiroyuki Kagechika, Shinsuke Yasuda
Anti-Inflammatory Effects of a Novel Nuclear Factor- κ B Inhibitory Derivative Derived from Pyrazolo[3,4- d ]Pyrimidine in Three Inflammation Models. The Journal of pharmacology and experimental therapeutics 388 (3) (2024)
Hiroyuki Baba, Tadashi Hosoya, Ryosuke Ishida, Kenpei Tai, Saki Hatsuzawa, Yuma Kondo, Hiroyuki Kusuhara, Hiroyuki Kagechika, Shinsuke Yasuda
Anti-Inflammatory Effects of a Novel Nuclear Factor- κ B Inhibitory Derivative Derived from Pyrazolo[3,4- d ]Pyrimidine in Three Inflammation Models. The Journal of pharmacology and experimental therapeutics 388 (3) (2024)
Hiroyuki Baba, Tadashi Hosoya, Ryosuke Ishida, Kenpei Tai, Saki Hatsuzawa, Yuma Kondo, Hiroyuki Kusuhara, Hiroyuki Kagechika, Shinsuke Yasuda
Anti-Inflammatory Effects of a Novel Nuclear Factor- κ B Inhibitory Derivative Derived from Pyrazolo[3,4- d ]Pyrimidine in Three Inflammation Models. The Journal of pharmacology and experimental therapeutics 388 (3) (2024)
Hiroyuki Baba, Naoki Kimura, Hirokazu Kanegane, Fuyuki Miya, Kenjiro Kosaki, Tomohiro Morio, Ryuji Koike
GATA2 deficiency of a novel missense variant with multiorgan inflammation. Rheumatology (Oxford, England) 63 (8) (2024)
Hiroyuki Baba, Naoki Kimura, Hirokazu Kanegane, Fuyuki Miya, Kenjiro Kosaki, Tomohiro Morio, Ryuji Koike
GATA2 deficiency of a novel missense variant with multiorgan inflammation. Rheumatology (Oxford, England) 63 (8) (2024)
Takumi Matsumoto, Takahiko Sugihara, Tadashi Hosoya, Tatsuro Ishizaki, Kanae Kubo, Mari Kamiya, Hiroyuki Baba, Marina Tsuchida, Fumio Hirano, Masayo Kojima, Nobuyuki Miyasaka, Masayoshi Harigai
Effectiveness and safety of treat-to-target strategy for methotrexate-naïve rheumatoid arthritis patients >75 years of age. Rheumatology advances in practice 8 (1) (2024)